Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1

References

Arbour, N., Day, R., Newcombe, J., and Talbot, P.J. (2000). Neuroinvasion by human respiratory coronaviruses. J. Virol. 74: 8913–8921, https://doi.org/10.1128/jvi.74.19.8913-8921.2000.Suche in Google Scholar PubMed PubMed Central

Barnes, B.J., Adrover, J.M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J.M., Dassler-Plenker, J., Guerci, P., Huynh, C., Knight, J.S., et al.. (2020). Targeting potential drivers of COVID-19: neutrophil extracellular traps. J. Exp. Med. 217: e20200652, https://doi.org/10.1084/jem.20200652.Suche in Google Scholar PubMed PubMed Central

Beazley-Long, N., Hua, J., Jehle, T., Hulse, R.P., Dersch, R., Lehrling, C., Bevan, H., Qiu, Y., Lagrèze, W.A., Wynick, D., et al.. (2013). VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am. J. Pathol. 183: 918–929, https://doi.org/10.1016/j.ajpath.2013.05.031.Suche in Google Scholar PubMed PubMed Central

Bernal-Bello, D., Jaenes-Barrios, B., Morales-Ortega, A., Ruiz-Giardin, J.M., García-Bermúdez, V., Frutos-Pérez, B., Farfán-Sedano, A.I., de Ancos-Aracil, C., Bermejo, F., and García-Gil, M. (2020). Imatinib might constitute a treatment option for lung involvement in COVID-19. Autoimmun. Rev. 218: 108518.10.1016/j.autrev.2020.102565Suche in Google Scholar PubMed PubMed Central

Blanco-Melo, D., Nilsson-Payant, B., Liu, W.-C., Møller, R., Panis, M., Sachs, D., and Albrecht, R. (2020). SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. Cell. 181(5): 1036–1045, doi:10.1016/j.cell.2020.04.026. 32416070.10.1101/2020.03.24.004655Suche in Google Scholar PubMed

Brea, D., Sobrino, T., Rodríguez-Yáñez, M., Ramos-Cabrer, P., Agulla, J., Rodríguez-González, R., Campos, F., Blanco, M., and Castillo, J. (2011). Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin. Immunol. 139: 193–198, https://doi.org/10.1016/j.clim.2011.02.001.Suche in Google Scholar PubMed

Cabler, S., French, A., and Orvedahl, A. (2020). A cytokine circus with a viral ringleader: SARS-CoV-2-associated cytokine storm syndromes. Trends Mol. Med. 26: 1078–1085, https://doi.org/10.1016/j.molmed.2020.09.012.Suche in Google Scholar PubMed PubMed Central

Cameron, M.J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J.F., Cameron, C.M., Muller, M.P., Gold, W.L., Richardson, S.E., Poutanen, S.M., et al.. (2007). Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 81: 8692–8706, https://doi.org/10.1128/jvi.00527-07.Suche in Google Scholar PubMed PubMed Central

Cantuti-Castelvetri, L., Ojha, R., Pedro, L.D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al.. (2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370: 856–860, https://doi.org/10.1126/science.abd2985.Suche in Google Scholar PubMed PubMed Central

Carboni, S., Aboul-Enein, F., Waltzinger, C., Killeen, N., Lassmann, H., and Peña-Rossi, C. (2003). CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J. Neuroimmunol. 145: 1–11.https://doi.org/10.1016/j.jneuroim.2003.07.001.Suche in Google Scholar PubMed

Cardona, G.C., Pájaro, L.D.Q., Marzola, I.D.Q., Villegas, Y.R., and Salazar, L.R.M. (2020). Neurotropism of SARS-CoV 2: mechanisms and manifestations. J. Neurol. Sci. 412: 116824, https://doi.org/10.1016/j.jns.2020.116824.Suche in Google Scholar PubMed PubMed Central

Cariboni, A., Davidson, K., Dozio, E., Memi, F., Schwarz, Q., Stossi, F., Parnavelas, J.G., and Ruhrberg, C. (2011). VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels. Development 138: 3723–3733, https://doi.org/10.1242/dev.063362.Suche in Google Scholar PubMed PubMed Central

Cavalcante, P., Galbardi, B., Franzi, S., Marcuzzo, S., Barzago, C., Bonanno, S., Camera, G., Maggi, L., Kapetis, D., and Andreetta, F. (2016). Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection. Immunobiology 221: 516–527, https://doi.org/10.1016/j.imbio.2015.12.007.Suche in Google Scholar PubMed

Che, Y., Qiu, J., Jin, T., Yin, F., Li, M., and Jiang, Y. (2016). Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain–Barré syndrome. Sci. Rep. 6: 20963, https://doi.org/10.1038/srep20963.Suche in Google Scholar PubMed PubMed Central

Chen, P., Yan, Q., Wang, S., Wang, C., and Zhao, P. (2016). Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer’s disease. Gene 587: 59–63, https://doi.org/10.1016/j.gene.2016.04.032.Suche in Google Scholar PubMed

Chen, W. (2020). A potential treatment of COVID-19 with TGF-β blockade. Int. J. Biol. Sci. 16: 1954–1955, https://doi.org/10.7150/ijbs.46891.Suche in Google Scholar PubMed PubMed Central

Cheng, Y., Wong, R., Soo, Y., Wong, W., Lee, C., Ng, M., Chan, P., Wong, K., Leung, C., and Cheng, G. (2005). Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 24: 44–46, https://doi.org/10.1007/s10096-004-1271-9.Suche in Google Scholar PubMed PubMed Central

Colotta, F., Re, F., Polentarutti, N., Sozzani, S., and Mantovani, A. (1992). Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012–2020, https://doi.org/10.1182/blood.v80.8.2012.2012.Suche in Google Scholar

Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N., and Decroly, E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 176: 104742, https://doi.org/10.1016/j.antiviral.2020.104742.Suche in Google Scholar PubMed PubMed Central

Cronstein, B.N., Molad, Y., Reibman, J., Balakhane, E., Levin, R.I., and Weissmann, G. (1995). Colchicine alters the quantitative and qualitative display of selections on endothelial cells and neutrophils. J. Clin. Invest. 96: 994–1002, https://doi.org/10.1172/jci118147.Suche in Google Scholar PubMed PubMed Central

Csencsits-Smith, K., Suescun, J., Li, K., Luo, S., Bick, D.L., and Schiess, M. (2016). Serum lymphocyte-associated cytokine concentrations change more rapidly over time in multiple system atrophy compared to Parkinson disease. Neuroimmunomodulation 23: 301–308, https://doi.org/10.1159/000460297.Suche in Google Scholar

Cuervo, N.Z. and Grandvaux, N. (2020). ACE2: evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 9: e61390, https://doi.org/10.7554/eLife.61390.Suche in Google Scholar

Cufi, P., Dragin, N., Weiss, J.M., Martinez‐Martinez, P., De Baets, M.H., Roussin, R., Fadel, E., Berrih‐Aknin, S., and Le Panse, R. (2013). Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Ann. Neurol. 73: 281–293, https://doi.org/10.1002/ana.23791.Suche in Google Scholar

Čulić, O., Eraković, V., Čepelak, I., Barišić, K., Brajša, K., Ferenčić, Ž., Galović, R., Glojnarić, I., Manojlović, Z., Munić, V., et al.. (2002). Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur. J. Pharmacol. 450: 277–289.10.1016/S0014-2999(02)02042-3Suche in Google Scholar

Daly, J.L., Simonetti, B., Klein, K., Chen, K.-E., Williamson, M.K., Antón-Plágaro, C., Shoemark, D.K., Simón-Gracia, L., Bauer, M., Hollandi, R., et al.. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370: 861–865, https://doi.org/10.1126/science.abd3072.Suche in Google Scholar PubMed

Davies, J., Randeva, H.S., Chatha, K., Hall, M., Spandidos, D.A., Karteris, E., and Kyrou, I. (2020). Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol. Med. Rep. 22: 4221–4226, https://doi.org/10.3892/mmr.2020.11510.Suche in Google Scholar PubMed PubMed Central

De Rivero Vaccari, J.P., Brand, F.J., Sedaghat, C., Mash, D.C., Dietrich, W.D., and Keane, R.W. (2014). RIG-1 Receptor expression in the pathology of Alzheimer’s disease. J. Neuroinflammation 11: 67, https://doi.org/10.1186/1742-2094-11-67.Suche in Google Scholar PubMed PubMed Central

De Virgiliis, F. and Di Giovanni, S. (2020). Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat. Rev. Neurol. 16: 645–652.10.1038/s41582-020-0402-ySuche in Google Scholar PubMed PubMed Central

Deng, L., Pan, J., Peng, Q., Dong, Z., and Wang, Y. (2017). Toll-like receptor 3 and interferon β mRNA expressions were increased in peripheral blood of ischemic stroke patients with good outcome. J. Stroke Cerebrovasc. Dis. 26: 559–566, https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.122.Suche in Google Scholar PubMed

Derkow, K., Bauer, J.M., Hecker, M., Paap, B.K., Thamilarasan, M., Koczan, D., Schott, E., Deuschle, K., Bellmann-Strobl, J., Paul, F., et al.. (2013). Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells. PLoS One 8: e70626, https://doi.org/10.1371/journal.pone.0070626.Suche in Google Scholar PubMed PubMed Central

Desideri, G., Cipollone, F., Necozione, S., Marini, C., Lechiara, M.C., Taglieri, G., Zuliani, G., Fellin, R., Mezzetti, A., Di Orio, F., et al.. (2008). Enhanced soluble CD40 ligand and Alzheimer’s disease: evidence of a possible pathogenetic role. Neurobiol. Aging 29: 348–356, https://doi.org/10.1016/j.neurobiolaging.2006.10.019.Suche in Google Scholar PubMed

Diaz, J.H. (2020). Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J. Travel Med. 27, taaa041, https://doi.org/10.1093/jtm/taaa041.Suche in Google Scholar PubMed PubMed Central

Didangelos, A. (2020). COVID-19 hyperinflammation: what about neutrophils?, mSphere. 5: e00367–e00320. https://doi.org/10.1128/mSphere.00367-20.Suche in Google Scholar PubMed PubMed Central

Dumond, A., Brachet, E., Durivault, J., Vial, V., Puszko, A.K., Lepelletier, Y., Montemagno, C., Pagnuzzi-Boncompagni, M., Hermine, O., Garbay, C., et al.. (2021). Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma. J. Exp. Clin. Cancer Res. 40: 1–18, https://doi.org/10.1186/s13046-021-01832-x.Suche in Google Scholar PubMed PubMed Central

Durante, M.A., Kurtenbach, S., Sargi, Z.B., Harbour, J.W., Choi, R., Kurtenbach, S., Goss, G.M., Matsunami, H., and Goldstein, B.J. (2020). Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nat. Neurosci. 23: 323–326, https://doi.org/10.1038/s41593-020-0587-9.Suche in Google Scholar PubMed PubMed Central

Fajgenbaum, D.C. and June, C.H. (2020). Cytokine storm. N. Engl. J. Med. 383: 2255–2273, https://doi.org/10.1056/nejmra2026131.Suche in Google Scholar

Famous, K.R., Delucchi, K., Ware, L.B., Kangelaris, K.N., Liu, K.D., Thompson, B.T., and Calfee, C.S. (2017). Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am. J. Respir. Crit. Care Med. 195: 331–338, https://doi.org/10.1164/rccm.201603-0645oc.Suche in Google Scholar

Fazzini, E., Fleming, J., and Fahn, S. (1992). Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov. Disord. 7: 153–158, https://doi.org/10.1002/mds.870070210.Suche in Google Scholar PubMed PubMed Central

Felderhoff-Mueser, U., Herold, R., Hochhaus, F., Koehne, P., Ring-Mrozik, E., Obladen, M., and Buhrer, C. (2001). Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus. Arch. Dis. Child. 84: 369–372, https://doi.org/10.1136/adc.84.4.369.Suche in Google Scholar PubMed PubMed Central

Geleijns, K., Laman, J.D., van Rijs, W., Tio-Gillen, A.P., Hintzen, R.Q., van Doorn, P.A., and Jacobs, B.C. (2005). Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain–Barré syndrome. J. Neuroimmunol. 161: 183–189, https://doi.org/10.1016/j.jneuroim.2004.12.001.Suche in Google Scholar PubMed

Ghode, S.S., Bajaj, M.S., Kulkarni, R.S., Limaye, L.S., Shouche, Y.S., and Kale, V.P. (2017). Neuropilin-1 is an important niche component and exerts context-dependent effects on hematopoietic stem cells. Stem Cell. Dev. 26: 35–48, https://doi.org/10.1089/scd.2016.0096.Suche in Google Scholar

González-Nicolás, M.Á., González-Guerrero, C., Pérez-Fernández, V.A., and Lázaro, A. (2020). Cilastatin: a potential treatment strategy against COVID-19 that may decrease viral replication and protect from the cytokine storm. Clin. Kidney J. 13: 903–905, https://doi.org/10.1093/ckj/sfaa193.Suche in Google Scholar

Gralinski, L.E., Sheahan, T.P., Morrison, T.E., Menachery, V.D., Jensen, K., Leist, S.R., Whitmore, A., Heise, M.T., and Baric, R.S. (2018). Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9: e01753–18, https://doi.org/10.1128/mBio.01753-18.Suche in Google Scholar

Guo, H.-F. and Vander Kooi, C.W. (2015). Neuropilin functions as an essential cell surface receptor. J. Biol. Chem. 290: 29120–29126, https://doi.org/10.1074/jbc.r115.687327.Suche in Google Scholar

Guo, J., Huang, Z., Lin, L., and Lv, J. (2020). Coronavirus disease 2019 (COVID‐19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J. Am. Heart Assoc. 9: e016219, https://doi.org/10.1161/JAHA.120.016219.Suche in Google Scholar

Gutierrez, E.G., Banks, W.A., and Kastin, A.J. (1993). Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47: 169–176, https://doi.org/10.1016/0165-5728(93)90027-v.Suche in Google Scholar

Haick, A.K., Rzepka, J.P., Brandon, E., Balemba, O.B., and Miura, T.A. (2014). Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology. J. Gen. Virol. 95: 578–590, https://doi.org/10.1099/vir.0.061986-0.Suche in Google Scholar PubMed PubMed Central

Hanchate, N.K., Giacobini, P., Lhuillier, P., Parkash, J., Espy, C., Fouveaut, C., Leroy, C., Baron, S., Campagne, C., Vanacker, C., et al.. (2012). SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. PLoS Genet. 8: e1002896, https://doi.org/10.1371/journal.pgen.1002896.Suche in Google Scholar PubMed PubMed Central

Herold, T., Jurinovic, V., Arnreich, C., Lipworth, B.J., Hellmuth, J.C., von Bergwelt-Baildon, M., Klein, M., and Weinberger, T. (2020). Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J. Allergy Clin. Immunol. 146: 128–136.e4, https://doi.org/10.1016/j.jaci.2020.05.008.Suche in Google Scholar PubMed PubMed Central

Hintzen, R.Q., Paty, D., and Oger, J. (1999). Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 66: 791–793, https://doi.org/10.1136/jnnp.66.6.791.Suche in Google Scholar PubMed PubMed Central

Hirano, T. and Murakami, M. (2020). COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52: 731–733, https://doi.org/10.1016/j.immuni.2020.04.003.Suche in Google Scholar

Hopkins, C., Lechien, J.R., and Saussez, S. (2021). More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med. Hypotheses 146: 110406, https://doi.org/10.1016/j.mehy.2020.110406.Suche in Google Scholar

Huang, K.J., Su, I.J., Theron, M., Wu, Y.C., Lai, S.K., Liu, C.C., and Lei, H.Y. (2005). An interferon‐γ‐related cytokine storm in SARS patients. J. Med. Virol. 75: 185–194, https://doi.org/10.1002/jmv.20255.Suche in Google Scholar

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al.. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497–506, https://doi.org/10.1016/s0140-6736(20)30183-5.Suche in Google Scholar

Hulse, R.P. (2017). Role of VEGF-A in chronic pain. Oncotarget 8: 10775, https://doi.org/10.18632/oncotarget.14615.Suche in Google Scholar PubMed PubMed Central

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al.. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436: 112–116, https://doi.org/10.1038/nature03712.Suche in Google Scholar PubMed PubMed Central

Isacson, O. (2020). The consequences of coronavirus-induced cytokine storm are associated with neurological diseases, which may be preventable. Front. Neurol. 11: 745, https://doi.org/10.3389/fneur.2020.00745.Suche in Google Scholar PubMed PubMed Central

Jarvis, A., Allerston, C.K., Jia, H., Herzog, B., Garza-Garcia, A., Winfield, N., Ellard, K., Aqil, R., Lynch, R., Chapman, C., et al.. (2010). Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J. Med. Chem. 53: 2215–2226, https://doi.org/10.1021/jm901755g.Suche in Google Scholar PubMed PubMed Central

Johnson, T.P., Tyagi, R., Patel, K., Schiess, N., Calabresi, P.A., and Nath, A. (2013). Impaired toll-like receptor 8 signaling in multiple sclerosis. J. Neuroinflammation 10: 1–4, https://doi.org/10.1186/1742-2094-10-74.Suche in Google Scholar PubMed PubMed Central

Kielian, M. (2020). Enhancing host cell infection by SARS-CoV-2. Science 370: 765–766, https://doi.org/10.1126/science.abf0732.Suche in Google Scholar PubMed

Kriszta, G., Kriszta, Z., Váncsa, S., Hegyi, P.J., Frim, L., Erőss, B., Hegyi, P., Pethő, G., and Pintér, E. (2021). Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on angiotensin-converting enzyme 2 levels: a comprehensive analysis based on animal studies. Front. Pharmacol. 12: 619524, https://doi.org/10.3389/fphar.2021.619524.Suche in Google Scholar PubMed PubMed Central

Kyrou, I., Randeva, H.S., Spandidos, D.A., and Karteris, E. (2021). Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19. Signal. Transduct. Target. Ther. 6: 1–3, https://doi.org/10.1038/s41392-020-00460-9.Suche in Google Scholar PubMed PubMed Central

Lamontagne, F., Agoritsas, T., Siemieniuk, R., Rochwerg, B., Bartoszko, J., Askie, L., Macdonald, H., Amin, W., Bausch, F.J., Burhan, E., et al.. (2021). A living WHO guideline on drugs to prevent COVID-19. BMJ 372: n526, https://doi.org/10.1136/bmj.n526.Suche in Google Scholar PubMed

Landau, A.M., Luk, K.C., Jones, M.-L., Siegrist-Johnstone, R., Young, Y.K., Kouassi, E., Rymar, V.V., Dagher, A., Sadikot, A.F., and Desbarats, J. (2005). Defective Fas expression exacerbates neurotoxicity in a model of Parkinson’s disease. J. Exp. Med. 202: 575–581, https://doi.org/10.1084/jem.20050163.Suche in Google Scholar PubMed PubMed Central

Lehmann, S.M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al.. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15: 827–835, https://doi.org/10.1038/nn.3113.Suche in Google Scholar PubMed

Li, Y., Zeng, Z., Cao, Y., Liu, Y., Ping, F., Liang, M., Xue, Y., Xi, C., Zhou, M., and Jiang, W. (2016). Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Sci. Rep. 6: 27911, https://doi.org/10.1038/srep27911.Suche in Google Scholar PubMed PubMed Central

Li, J., Sun, Y., and Chen, J. (2019). Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson’s disease. Genes Genet. Syst. 94: 61–69, https://doi.org/10.1266/ggs.18-00036.Suche in Google Scholar PubMed

Liu, B., Li, M., Zhou, Z., Guan, X., and Xiang, Y. (2020a). Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun. 111: 102452, https://doi.org/10.1016/j.jaut.2020.102452.Suche in Google Scholar PubMed PubMed Central

Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al.. (2020b). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 63: 364–374, https://doi.org/10.1007/s11427-020-1643-8.Suche in Google Scholar PubMed PubMed Central

Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al.. (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26: 1200–1204, https://doi.org/10.1038/s41591-020-0965-6.Suche in Google Scholar PubMed

Longping, V.T., Hamilton, A.M., Friling, T., and Whittaker, G.R. (2014). A novel activation mechanism of avian influenza virus H9N2 by furin. J. Virol. 88: 1673–1683, https://doi.org/10.1128/JVI.02648-13.Suche in Google Scholar PubMed PubMed Central

Lopes, M.I., Bonjorno, L.P., Giannini, M.C., Amaral, N.B., Menezes, P.I., Dib, S.M., Gigante, S.L., Benatti, M.N., Rezek, U.C., Emrich-Filho, L.L., et al.. (2021). Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open 7: e001455, https://doi.org/10.1136/rmdopen-2020-001455.Suche in Google Scholar PubMed PubMed Central

López, R.L., Fernández, S.C., Pérez, L.L., Palacios, A.R., Fernández-Roldán, M.C., Alonso, E.A., Camacho, I.P., Rodriguez-Baño, J., Merchante, N., Olalla, J., et al.. (2020). Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ Open 10: e039951, https://doi.org/10.1136/bmjopen-2020-039951.Suche in Google Scholar PubMed PubMed Central

Louapre, C., Collongues, N., Stankoff, B., Giannesini, C., Papeix, C., Bensa, C., Deschamps, R., Créange, A., Wahab, A., Pelletier, J., et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 77: 1079–1088, https://doi.org/10.1001/jamaneurol.2020.2581.Suche in Google Scholar PubMed PubMed Central

Lu, Y., Liu, D.X., and Tam, J.P. (2008). Lipid rafts are involved in SARS-CoV entry into Vero E6 cells. Biochem. Biophys. Res. Commun. 369: 344–349, https://doi.org/10.1016/j.bbrc.2008.02.023.Suche in Google Scholar PubMed PubMed Central

Ma, J., Ketkar, H., Geng, T., Lo, E., Wang, L., Xi, J., Sun, Q., Zhu, Z., Cui, Y., Yang, L., et al.. (2018). Zika virus non-structural protein 4A blocks the RLR-MAVS signaling. Front. Microbiol. 9: 1350, https://doi.org/10.3389/fmicb.2018.01350.Suche in Google Scholar PubMed PubMed Central

Maes, B., Bosteels, C., De Leeuw, E., Declercq, J., Van Damme, K., Delporte, A., Demeyere, B., Vermeersch, S., Vuylsteke, M., Willaert, J., et al.. (2020). Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): a structured summary of a study protocol for a randomised controlled trial. Trials 21: 1–2, https://doi.org/10.1186/s13063-020-04453-5.Suche in Google Scholar PubMed PubMed Central

Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., and Nabipour, I. (2020). COVID-19 cytokine storm: the anger of inflammation. Cytokine 133: 155151, https://doi.org/10.1016/j.cyto.2020.155151.Suche in Google Scholar PubMed PubMed Central

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al.. (2020a). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77: 683–690, https://doi.org/10.1001/jamaneurol.2020.1127.Suche in Google Scholar PubMed PubMed Central

Mao, L.-L., Chen, W.-Y., Ma, A.-J., Ji, L.-L., and Huang, T.-T. (2020b). High serum OX40 ligand correlates with severity and mortality in patients with massive cerebral infarction. Medicine 99: e20883, https://doi.org/10.1097/md.0000000000020883.Suche in Google Scholar PubMed PubMed Central

Margaryan, S., Witkowicz, A., Arakelyan, A., Partyka, A., Karabon, L., and Manukyan, G. (2018). sFasL-mediated induction of neutrophil activation in patients with type 2 diabetes mellitus. PLoS One 13: e0201087, https://doi.org/10.1371/journal.pone.0201087.Suche in Google Scholar

Mattson, M.P. (1997). Neuroprotective signal transduction: relevance to stroke. Neurosci. Biobehav. Rev. 21: 193–206, https://doi.org/10.1016/s0149-7634(96)00010-3.Suche in Google Scholar

McGonagle, D., Sharif, K., O’Regan, A., and Bridgewood, C. (2020). The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 19: 102537, https://doi.org/10.1016/j.autrev.2020.102537.Suche in Google Scholar

Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S., and Manson, J.J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033–1034, https://doi.org/10.1016/s0140-6736(20)30628-0.Suche in Google Scholar

Meng, J., Xiao, G., Zhang, J., He, X., Ou, M., Bi, J., Yang, R., Di, W., Wang, Z., and Li, Z. (2020). Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9: 757–760, https://doi.org/10.1080/22221751.2020.1746200.Suche in Google Scholar PubMed PubMed Central

Merzon, E., Green, I., Vinker, S., Golan‐Cohen, A., Gorohovski, A., Avramovich, E., Frenkel‐Morgenstern, M., and Magen, E. (2021). The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection. FEBS J., https://doi.org/10.1111/febs.15784 (Epub ahead of print).Suche in Google Scholar PubMed PubMed Central

Meshkat, S., Salimi, A., Joshaghanian, A., Sedighi, S., Sedighi, S., and Aghamollaii, V. (2020). Chronic neurological diseases and COVID-19: associations and considerations. Transl. Neurosci. 11: 294–301, https://doi.org/10.1515/tnsci-2020-0141.Suche in Google Scholar PubMed PubMed Central

Middleton, E.A., He, X.-Y., Denorme, F., Campbell, R.A., Ng, D., Salvatore, S.P., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A.C., Loda, M., et al.. (2020). Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136: 1169–1179, https://doi.org/10.1182/blood.2020007008.Suche in Google Scholar PubMed PubMed Central

Mogi, M., Fukuo, K., Yang, J., Suhara, T., and Ogihara, T. (2001). Hypoxia stimulates release of the soluble form of fas ligand that inhibits endothelial cell apoptosis. Lab. Invest. 81: 177–184, https://doi.org/10.1038/labinvest.3780225.Suche in Google Scholar PubMed

Moin, A.S.M., Sathyapalan, T., Atkin, S.L., and Butler, A.E. (2021). The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol. Open 9: 100079, https://doi.org/10.1016/j.metop.2021.100079.Suche in Google Scholar PubMed PubMed Central

Morales, D.R., Conover, M.M., You, S.C., Pratt, N., Kostka, K., Duarte-Salles, T., Fernández-Bertolín, S., Aragón, M., DuVall, S.L., et al.. (2021). Angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit. Health 3: e98–e114, https://doi.org/10.1016/s2589-7500(20)30289-2.Suche in Google Scholar

Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R.A., Aisen, P.S., and Turner, R.S. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J. Neuroinflammation 14: 1, https://doi.org/10.1186/s12974-016-0779-0.Suche in Google Scholar PubMed PubMed Central

Moutal, A., Martin, L.F., Boinon, L., Gomez, K., Ran, D., Zhou, Y., Stratton, H.J., Cai, S., Luo, S., Gonzalez, K.B., et al.. (2021). SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 162: 243–252, https://doi.org/10.1097/j.pain.0000000000002097.Suche in Google Scholar PubMed PubMed Central

Nagata, S. and Golstein, P. (1995). The Fas death factor. Science 267: 1449–1456, https://doi.org/10.1126/science.7533326.Suche in Google Scholar PubMed

Nakanishi, T., Fujita, Y., and Yamashita, T. (2019). Neuropilin-1-mediated pruning of corticospinal tract fibers is required for motor recovery after spinal cord injury. Cell Death Dis. 10: 1–11, https://doi.org/10.1038/s41419-019-1338-2.Suche in Google Scholar PubMed PubMed Central

Netland, J., Meyerholz, D.K., Moore, S., Cassell, M., and Perlman, S. (2008). Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 82: 7264–7275, https://doi.org/10.1128/jvi.00737-08.Suche in Google Scholar

Ottonello, L., Tortolina, G., Amelotti, M., and Dallegri, F. (1999). Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J. Immunol. 162: 3601–3606.10.4049/jimmunol.162.6.3601Suche in Google Scholar

Pan, W., Xiang, S., Tu, H., and Kastin, A. (2006). Blood-brain barrier interfaces: from ontogeny to artificial barriers. Q. Rev. Biol. 81: 423.Suche in Google Scholar

Peng, Y.-J., Peng, C.-T., Lin, Y.-H., Lin, G.-J., Huang, S.-H., Chen, S.-J., Sytwu, H.-K., and Cheng, C.-P. (2020). Decoy receptor 3 promotes preosteoclast cell death via reactive oxygen species-induced fas ligand expression and the IL-1α/IL-1 receptor antagonist pathway. Mediators Inflamm. 2020: 1237281, https://doi.org/10.1155/2020/1237281.Suche in Google Scholar PubMed PubMed Central

Perez-Miller, S., Patek, M., Moutal, A., Duran, P., Cabel, C.R., Thorne, C.A., Campos, S.K., and Khanna, R. (2021). Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry. ACS Chem. Neurosci. 12: 1299–1312, https://doi.org/10.1021/acschemneuro.0c00619.Suche in Google Scholar PubMed PubMed Central

Pettit, N.N., MacKenzie, E.L., Ridgway, J.P., Pursell, K., Ash, D., Patel, B., and Pho, M.T. (2020). Obesity is associated with increased risk for mortality among hospitalized patients with COVID‐19. Obesity 28: 1806–1810, https://doi.org/10.1002/oby.22941.Suche in Google Scholar PubMed PubMed Central

Powell, J., Mota, F., Steadman, D., Soudy, C., Miyauchi, J.T., Crosby, S., Jarvis, A., Reisinger, T., Winfield, N., Evans, G., et al.. (2018). Small molecule neuropilin-1 antagonists combine antiangiogenic and antitumor activity with immune modulation through reduction of transforming growth factor beta (TGFβ) production in regulatory T-cells. J. Med. Chem. 61: 4135–4154, https://doi.org/10.1021/acs.jmedchem.8b00210.Suche in Google Scholar PubMed PubMed Central

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., and Wang, W. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71 (15) : 762–768, https://doi.org/10.1093/cid/ciaa248.Suche in Google Scholar

Rahmani, A., Baee, M., Saleki, K., Moradi, S., and Nouri, H.R. (2021). Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2. J. Biomol. Struct. Dyn.: 1–17, https://doi.org/10.1080/07391102.2021.1876774.Suche in Google Scholar

Rahmani, A., Saleki, K., Javanmehr, N., Khodaparast, J., Saadat, P., and Nouri, H.R. (2020). Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke. Ageing Res. Rev. 62: 101106, https://doi.org/10.1016/j.arr.2020.101106.Suche in Google Scholar

Raine, C., Bonetti, B., and Cannella, B. (1998). Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev. Neurol. 154: 577–585.Suche in Google Scholar

Rasoulinejad, S.A., Karkhah, A., Paniri, A., Saleki, K., Pirzadeh, M., and Nouri, H.R. (2020). Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy. Immunopharmacol. Immunotoxicol. 42: 400–407, https://doi.org/10.1080/08923973.2020.1808986.Suche in Google Scholar

Ray, P.R., Wangzhou, A., Ghneim, N., Yousuf, M.S., Paige, C., Tavares-Ferreira, D., Mwirigi, J.M., Shiers, S., Sankaranarayanan, I., McFarland, A.J., et al.. (2020). A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction. Brain Behav. Immun. 89: 559–568, https://doi.org/10.1016/j.bbi.2020.05.078.Suche in Google Scholar

Reichard, R.R., Kashani, K.B., Boire, N.A., Constantopoulos, E., Guo, Y., and Lucchinetti, C.F. (2020). Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 140: 1–6, https://doi.org/10.1007/s00401-020-02166-2.Suche in Google Scholar

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., and Stebbing, J. (2020). Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395: e30–e31, https://doi.org/10.1016/s0140-6736(20)30304-4.Suche in Google Scholar

Ryabkova, V.A., Churilov, L.P., and Shoenfeld, Y. (2020). Influenza infection, SARS, MERS and COVID-19: cytokine storm–the common denominator and the lessons to be learned. Clin. Immunol. 223: 108652, https://doi.org/10.1016/j.clim.2020.108652.Suche in Google Scholar PubMed PubMed Central

Salah, H.M. and Mehta, J.L. (2021). Meta-Analysis of the effect of aspirin on mortality in COVID-19. Am. J. Cardiol. 142: 158–159, https://doi.org/10.1016/j.amjcard.2020.12.073.Suche in Google Scholar PubMed PubMed Central

Salehi, P., Ge, M.X., Gundimeda, U., Michelle Baum, L., Lael Cantu, H., Lavinsky, J., Tao, L., Myint, A., Cruz, C., and Wang, J. (2017). Role of neuropilin-1/semaphorin-3A signaling in the functional and morphological integrity of the cochlea. PLoS Genet. 13: e1007048, https://doi.org/10.1371/journal.pgen.1007048.Suche in Google Scholar PubMed PubMed Central

Saleki, K., Banazadeh, M., Saghazadeh, A., and Rezaei, N. (2020). The involvement of the central nervous system in patients with COVID-19. Rev. Neurosci. 31: 453–456, https://doi.org/10.1515/revneuro-2020-0026.Suche in Google Scholar PubMed

Saponaro, F., Rutigliano, G., Sestito, S., Bandini, L., Storti, B., Bizzarri, R., and Zucchi, R. (2020). ACE2 in the era of SARS-CoV-2: controversies and novel perspectives. Front. Mol. Biosci. 7: 588618, https://doi.org/10.3389/fmolb.2020.588618.Suche in Google Scholar PubMed PubMed Central

Saresella, M., Gatti, A., Tortorella, P., Marventano, I., Piancone, F., La Rosa, F., Caputo, D., Rovaris, M., Biasin, M., and Clerici, M. (2014). Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis. Clin. Immunol. 150: 109–120, https://doi.org/10.1016/j.clim.2013.10.012.Suche in Google Scholar PubMed

Saunders, J.A.H., Estes, K.A., Kosloski, L.M., Allen, H.E., Dempsey, K.M., Torres-Russotto, D.R., Meza, J.L., Santamaria, P.M., Bertoni, J.M., Murman, D.L., et al.. (2012). CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease. J. Neuroimmune Pharmacol. 7: 927–938, https://doi.org/10.1007/s11481-012-9402-z.Suche in Google Scholar PubMed PubMed Central

Serrao, K.L., Fortenberry, J.D., Owens, M.L., Harris, F.L., and Brown, L.A.S. (2001). Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. Lung Cell Mol. Physiol. 280: L298–L305, https://doi.org/10.1152/ajplung.2001.280.2.l298.Suche in Google Scholar

Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al.. (2020). Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. J. Am. Med. Assoc. 323: 1582–1589, https://doi.org/10.1001/jama.2020.4783.Suche in Google Scholar PubMed PubMed Central

Sherafat, A., Pfeiffer, F., Reiss, A.M., Wood, W.M., and Nishiyama, A. (2021). Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor. Nat. Commun. 12: 1–17, https://doi.org/10.1038/s41467-021-22532-2.Suche in Google Scholar PubMed PubMed Central

Siemieniuk, R.A., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M.A., et al.. (2020a). Drug treatments for COVID-19: living systematic review and network meta-analysis. BMJ 370: m2980, https://doi.org/10.1136/bmj.m2980.Suche in Google Scholar PubMed PubMed Central

Siemieniuk, R. A. C., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J. P. D., and Rochwerg, B. (2020b). Update to living systematic review on drug treatments for COVID-19. Br. Med. J. 370: m3536.Suche in Google Scholar

Siemieniuk, R. A. C., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J. P. D., and Rochwerg, B. (2020c). Update to living systematic review on drug treatments for COVID-19. Br. Med. J. 371: m4852.Suche in Google Scholar

Siemieniuk, R. A. C., Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J. P. D., and Rochwerg, B. (2021a). Update to living systematic review on drug treatments for COVID-19. Br. Med. J. 372: n858.Suche in Google Scholar

Siemieniuk, RA, Bartoszko, J.J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M.H., et al.. (2021b). Drug treatments for COVID-19: living systematic review and network meta-analysis. BMJ. 373: n967.10.1136/bmj.m2980Suche in Google Scholar

Sinha, P., Delucchi, K.L., Thompson, B.T., McAuley, D.F., Matthay, M.A., and Calfee, C.S. (2018). Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 44: 1859–1869, https://doi.org/10.1007/s00134-018-5378-3.Suche in Google Scholar PubMed PubMed Central

Sinha, P., Matthay, M.A., and Calfee, C.S. (2020). Is a “cytokine storm” relevant to COVID-19? JAMA Intern. Med. 180: 1152–1154, https://doi.org/10.1001/jamainternmed.2020.3313.Suche in Google Scholar

Skipper, C.P., Pastick, K.A., Engen, N.W., Bangdiwala, A.S., Abassi, M., Lofgren, S.M., Williams, D.A., Okafor, E.C., Pullen, M.F., Nicol, M.R., et al.. (2020). Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann. Intern. Med. 173: 623–631, https://doi.org/10.7326/m20-4207.Suche in Google Scholar

Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735–745, https://doi.org/10.1016/s0092-8674(00)81402-6.Suche in Google Scholar

Spray, D.C., Dermietzel, R., and Nedergaard, M. (2006). Blood-brain barriers: from ontogeny to artificial interfaces, (2 volume set). Wiley, Hoboken, New Jersey, p. 1.10.1002/9783527611225Suche in Google Scholar

Su, J.H., Anderson, A.J., Cribbs, D.H., Tu, C., Tong, L., Kesslack, P., and Cotman, C.W. (2003). Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death. Neurobiol. Dis. 12: 182–193.10.1016/S0969-9961(02)00019-0Suche in Google Scholar

Suidan, G.L., Dickerson, J.W., Johnson, H.L., Chan, T.W., Pavelko, K.D., Pirko, I., Seroogy, K.B., and Johnson, A.J. (2012). Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability. J. Neuroinflammation 9: 218.10.1186/1742-2094-9-218Suche in Google Scholar PubMed PubMed Central

Suzuki, Y., Nakano, Y., Mishiro, K., Takagi, T., Tsuruma, K., Nakamura, M., Yoshimura, S., Shimazawa, M., and Hara, H. (2013). Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci. Rep. 3: 1–7.10.1038/srep03177Suche in Google Scholar PubMed PubMed Central

Tay, M.Z., Poh, C.M., Rénia, L., MacAry, P.A., and Ng, L.F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20: 363–374.10.1038/s41577-020-0311-8Suche in Google Scholar PubMed PubMed Central

Teesalu, T., Sugahara, K.N., Kotamraju, V.R., and Ruoslahti, E. (2009). C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. U S A 106: 16157–16162.10.1073/pnas.0908201106Suche in Google Scholar PubMed PubMed Central

Turner, A.J. (2015). ACE2 cell biology, regulation, and physiological functions. In: The protective arm of the renin angiotensin system (RAS). Elsevier, p. 185.10.1016/B978-0-12-801364-9.00025-0Suche in Google Scholar

Tüzün, E., Scott, B.G., Goluszko, E., Higgs, S., and Christadoss, P. (2003). Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J. Immunol. 171: 3847–3854.10.4049/jimmunol.171.7.3847Suche in Google Scholar PubMed

Varzari, A., Bruch, K., Deyneko, I.V., Chan, A., Epplen, J.T., and Hoffjan, S. (2014). Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients. J. Neuroimmunol. 277: 140–144.10.1016/j.jneuroim.2014.09.015Suche in Google Scholar PubMed

Volpe, E., Sambucci, M., Battistini, L., and Borsellino, G. (2016). Fas–fas ligand: checkpoint of t cell functions in multiple sclerosis. Front. Immunol. 7: 382.10.3389/fimmu.2016.00382Suche in Google Scholar PubMed PubMed Central

Walls, A.C., Park, Y.-J., Tortorici, M.A., Wall, A., McGuire, A.T., and Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181: 281–292.10.1016/j.cell.2020.02.058Suche in Google Scholar PubMed PubMed Central

Wang, L., Azad, N., Kongkaneramit, L., Chen, F., Lu, Y., Jiang, B.-H., and Rojanasakul, Y. (2008). The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation. J. Immunol. 180: 3072–3080.10.4049/jimmunol.180.5.3072Suche in Google Scholar PubMed PubMed Central

Wang, Y.-Z., Liang, Q.-H., Ramkalawan, H., Wang, Y.-L., Yang, Y.-F., Zhou, W.-B., Tian, F.-F., Li, J., and Yang, H. (2012). Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome. Neuroimmunomodulation 19: 60–68.10.1159/000328200Suche in Google Scholar PubMed

Wang, Y.-L., Tan, M.-S., Yu, J.-T., Zhang, W., Hu, N., Wang, H.-F., Jiang, T., and Tan, L. (2013a). Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese. J. Neuroinflammation 10: 101.10.1186/1742-2094-10-101Suche in Google Scholar PubMed PubMed Central

Wang, Y.-Z., Yan, M., Tian, F.-F., Zhang, J.-M., Liu, Q., Yang, H., Zhou, W.-B., and Li, J. (2013b). Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis. Inflammation 36: 121–130.10.1007/s10753-012-9526-6Suche in Google Scholar PubMed

Wang, J., Liu, Y., Liu, Y., Zhu, K., and Xie, A. (2020). The association between TLR3 rs3775290 polymorphism and sporadic Parkinson’s disease in Chinese Han population. Neurosci. Lett. 728: 135005.10.1016/j.neulet.2020.135005Suche in Google Scholar PubMed

Woolf, S.H., Chapman, D.A., Sabo, R.T., Weinberger, D.M., and Hill, L. (2020). Excess deaths from COVID-19 and other causes, March–April 2020. J. Am. Med. Assoc. 324: 510–513.10.1001/jama.2020.11787Suche in Google Scholar PubMed PubMed Central

Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., et al.. (2020a). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180: 934–943.10.1001/jamainternmed.2020.0994Suche in Google Scholar

Wu, Z., Hu, R., Zhang, C., Ren, W., Yu, A., and Zhou, X. (2020b). Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit. Care 24: 1–3.10.1186/s13054-020-03015-0Suche in Google Scholar

Xiaoyan, Z., Pirskanen, R., Malmstrom, V., and Lefvert, A. (2006). Expression of OX40 (CD134) on CD4+ T‐cells from patients with myasthenia gravis. Clin. Exp. Immunol. 143: 110–116.10.1111/j.1365-2249.2005.02955.xSuche in Google Scholar

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al.. (2020a). Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. U S A 117: 10970–10975.10.1073/pnas.2005615117Suche in Google Scholar

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al.. (2020b). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8: 420–422.10.1016/S2213-2600(20)30076-XSuche in Google Scholar

Yao, X.H., Li, T.Y., He, Z.C., Ping, Y.F., Liu, H.W., Yu, S.C., Mou, H.M., Wang, L.H., Zhang, H.R., Fu, W.J., et al.. (2020). A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi 49: E009.Suche in Google Scholar

Yaqinuddin, A. and Kashir, J. (2020). Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using monalizumab, cholroquine, and antiviral agents. Med. Hypotheses 140: 109777.10.1016/j.mehy.2020.109777Suche in Google Scholar PubMed PubMed Central

Yasuhara, T., Shingo, T., and Date, I. (2004). The potential role of vascular endothelial growth factor in the central nervous system. Rev. Neurosci. 15: 293–307.10.1515/REVNEURO.2004.15.4.293Suche in Google Scholar

Yazdanpanah, N., Saghazadeh, A., and Rezaei, N. (2020). Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev. Neurosci. 31: 691–701.10.1515/revneuro-2020-0039Suche in Google Scholar PubMed

Yeh, E.A., Collins, A., Cohen, M.E., Duffner, P.K., and Faden, H. (2004). Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 113: e73–e76.10.1542/peds.113.1.e73Suche in Google Scholar PubMed

Yilmaz, V., Oflazer, P., Aysal, F., Parman, Y.G., Direskeneli, H., Deymeer, F., and Saruhan-Direskeneli, G.B. (2015). Cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis. Autoimmunity 48: 201–207.10.3109/08916934.2014.992517Suche in Google Scholar PubMed

Yongzhi, X. (2021). COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue. Emerg Microbes Infec. 10: 266–276.10.1080/22221751.2021.1884503Suche in Google Scholar

Zanin, L., Saraceno, G., Panciani, P.P., Renisi, G., Signorini, L., Migliorati, K., and Fontanella, M.M. (2020). SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 162: 1491–1494.10.1007/s00701-020-04374-xSuche in Google Scholar

Zelano, G., Lino, M., Evoli, A., Settesoldi, D., Batocchi, A.P., Torrente, I., and Tonali, P.A. (1998). Tumour necrosis factor β gene polymorphisms in myasthenia gravis. Eur. J. Immunogenet. 25: 403–408.10.1046/j.1365-2370.1998.00129.xSuche in Google Scholar

Zhang, H., Wang, Z., Liu, R., Qian, T., Liu, J., Wang, L., and Chu, Y. (2018). Reactive oxygen species stimulated pulmonary epithelial cells mediate the alveolar recruitment of FasL+ killer B cells in LPS‐induced acute lung injuries. J. Leukoc. Biol. 104: 1187–1198.10.1002/JLB.3A0218-075RSuche in Google Scholar

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al.. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054–1062.10.1016/S0140-6736(20)30566-3Suche in Google Scholar

Zhou, Y., Fang, L., Peng, L., and Qiu, W. (2017). TLR9 and its signaling pathway in multiple sclerosis. J. Neurol. Sci. 373: 95–99.10.1016/j.jns.2016.12.027Suche in Google Scholar PubMed

Zhu, K., Teng, J., Zhao, J., Liu, H., and Xie, A. (2016). Association of TLR9 polymorphisms with sporadic Parkinson’s disease in Chinese Han population. Int. J. Neurosci. 126: 612–616.10.3109/00207454.2015.1050591Suche in Google Scholar PubMed